Insider Trading & Ownership of Peter J. Graham

Location
New York, NY
Summary
The estimated net worth of Peter J. Graham is at least $2,475,954 dollars as of 18 Feb 2026. Peter J. Graham is the Chief Legal Officer of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $2.48M.
Signature
/s/ Lisa Kallebo, Attorney-in-Fact for Peter Graham
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Peter J. Graham and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Peter J. Graham has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,475,954.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ADC Therapeutics SA ($2,475,954).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Peter J. Graham

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ADCT ADC Therapeutics SA Chief Legal Officer $2,475,954 13 Feb 2026
ATRS ANTARES PHARMA, INC. EVP, General Counsel, Chief Compliance Officer and Secretary 24 May 2022

Insider Transactions Reported by Peter J. Graham:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .